Test Price
1,000 AED✅ Home Collection Available
S. pneumoniae, H. influenzae, C. pneumoniae, N. meningitidis Multiplex RNA Detection (Qualitative) Test in UAE | 1000 AED | 2026 DHA Guidelines
تحليل متعدد الكشف عن بكتيريا المكورات الرئوية والمستدمية النزلية والكلاميديا الرئوية والنيسرية السحائية (كشف الحمض النووي الريبي) في الإمارات | 1000 درهم | معتمد من هيئة الصحة بدبي
Executive Summary (ملخص تنفيذي)
99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Molecular Diagnostics. Premium Home Collection with Cold-Chain Logistics. Post-Test Telephonic Clinical Guidance. Direct Insurance Billing.
دقة تشخيصية بنسبة 99.9% من خلال مختبر حاصل على شهادة ISO 9001:2015. خدمة سحب منزلي متميزة بنظام سلسلة تبريد معتمدة. توجيه طبي هاتفي بعد النتيجة. تسوية مباشرة للتأمين.
WhatsApp for Insurance Verification & Booking: +971 54 548 8731
Overview
This multiplex molecular assay simultaneously detects RNA from Streptococcus pneumoniae, Haemophilus influenzae, Chlamydia pneumoniae, and Neisseria meningitidis, enabling rapid differentiation of bacterial respiratory and central nervous system infections. It delivers high-confidence qualitative results that guide targeted antimicrobial therapy, reduce empirical treatment delays, and are aligned with the 2026 DHA antimicrobial stewardship standards.
| Feature | Our Test | Closest Alternative (Conventional Culture) |
|---|---|---|
| Methodology | Multiplex Real-Time PCR (qPCR) with Whole Genome Sequencing confirmation | Bacterial culture & biochemical identification |
| Time to Result | Phone alert in 24 h; certified report within 3 working days | 3–5 days (viable organisms required) |
| Analytical Sensitivity | 99.9% (detects non-viable & fastidious pathogens) | 70–80%; viability-dependent |
| Sample Types | Nasopharyngeal swab, CSF, blood, bronchial lavage, nasopharyngeal secretions | Limited to viable specimen collected before antibiotics |
| Regulatory Status | DHA/MOHAP Approved | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Routine lab accreditation |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY, DHA License 61713011, states:
“As a physician, I understand that waiting for results of tests for serious infections can be unsettling. This multiplex RNA panel provides rapid and accurate pathogen identification, allowing for timely and precise treatment decisions. However, clinical assessment remains paramount — a negative result does not fully exclude infection, and any worsening of symptoms must be evaluated immediately in a medical facility.”
⚠️ Do not discontinue prescribed medication without consulting your doctor. This test aids diagnosis but does not replace clinical judgment.
Exclusion Criteria & Emergency Red Flags (معايير الاستبعاد والعلامات التحذيرية الطارئة)
- Exclusion Criteria: Patients on empiric broad-spectrum antibiotics can still be tested (nucleic acid detection is unaffected). However, prolonged prior therapy may lower sensitivity. No medication discontinuation is required for sample collection.
- Emergency Red Flags – Seek Immediate ER Care:
- Severe headache with neck stiffness and photophobia
- Altered mental status or confusion
- Non-blanching petechial or purpuric rash
- Rapid, labored breathing or chest pain
- High fever unresponsive to antipyretics
- Do not wait for test results if any of these signs appear.
Patient FAQ & Clinical Guidance
1. What is the purpose of this multiplex RNA detection test?
This test identifies RNA from four key bacterial pathogens — S. pneumoniae, H. influenzae, C. pneumoniae, and N. meningitidis — to rapidly diagnose pneumonia, meningitis, or sepsis, helping clinicians choose effective antibiotics without delay. It is particularly valuable when culture is negative due to prior antibiotic use.
2. How soon can I expect results after sample collection?
You will receive a preliminary phone result within 24 hours of sample arrival at the laboratory, enabling same-day clinical action. The final certified report is issued by the 3rd working day, integrating ISO-accredited quality control and WGS confirmation when indicated.
3. Is this covered by my UAE health insurance?
Most major UAE insurers cover the multiplex respiratory & meningeal pathogen panel when ordered by a licensed physician for suspected infection. Our billing team performs direct verification via WhatsApp at +971 54 548 8731 before the home collection, so you know your coverage status in advance.
UAE Regulatory & Quality Compliance
Reference: Federal Decree-Law No. 41 of 2024 (Art. 87) on Health Data Protection; CDS Law 2026 (Minors’ Consent); UAE PDPL.
Laboratory Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | DHA/MOHAP Licensed Facility No. 9834453.
Medical Disclaimer: This information is for educational purposes and does not replace a doctor’s consultation. Always seek professional medical advice.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians